GlaxoSmithKline PLC — Director's Dealing 2014

Apr 2, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8562D

GlaxoSmithKline PLC

02 April 2014

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 31 March 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.08 per Ordinary Share, and notional ADSs at a price of $53.75 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2014 to 31 March 2014:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	3,886.816
Professor Sir Roy Anderson	563.588
Dr Stephanie Burns		433.042
Stacey Cartwright	446.984
Lynn  Elsenhans		779.475
Judy Lewent		367.144
Sir Deryck Maughan		1,092.019
Dr Daniel Podolsky		819.014
Tom de Swaan	408.116
Jing Ulrich		216.521
Hans Wijers	446.984
Sir Robert Wilson	446.984

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

2 April 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSKLLBBZZFZBBK